Stereotactic Radiotherapy after Incomplete Transarterial (Chemo-) Embolization (TAE) versus Exclusive TAE or TACE for Treatment of Inoperable HCC: A Phase III Trial (NCT02323360)

Comito et al. (Wed,) studied this question.

www.synapsesocial.com/papers/6a006e6e2ff633f36577f053 — DOI: https://doi.org/10.3390/curroncol29110692

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. Hepatic toxicity resulting from cancer treatment· 1995 · 744 citations
2. Individualized Adaptive Stereotactic Body Radiotherapy for Liver Tumors in Patients at High Risk for Liver Damage· 2017 · 164 citations
3. The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level· 2017 · 2,011 citations
4. How to Define Transarterial Chemoembolization Failure or Refractoriness: A European Perspective· 2014 · 143 citations
5. Stereotactic Body Radiation Therapy as an Alternative to Transarterial Chemoembolization for Hepatocellular Carcinoma· 2017 · 198 citations